Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Lanyun Feng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8214-3942; OpenAlex author ID A5083214060. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 2 papers · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 6

  1. Digital subtraction angiography-guided pancreatic arterial infusion of GEMOX chemotherapy in advanced pancreatic adenocarcinoma: a phase II, open-label, random… Co-author DOI 10.1186/s12885-024-12695-8↗
  2. Integrative analysis reveals clinically relevant molecular fingerprints in pancreatic cancer. Co-author DOI 10.1016/j.omtn.2021.06.015↗
  3. Serum level of CCL2 predicts outcome of patients with pancreatic cancer. Co-author PMID 32603049↗
  4. Pretreatment values of bilirubin and albumin are not prognostic predictors in patients with advanced pancreatic cancer. Co-author DOI 10.1002/cam4.1848↗
  5. Serum levels of IL-6, IL-8, and IL-10 are indicators of prognosis in pancreatic cancer. Co-author DOI 10.1177/0300060518800588↗
  6. Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? An analysis from a large multicenter coh… Co-author DOI 10.18632/oncotarget.13000↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhen Chen · 5 shared papers, 2016–2024 · strength 0.55
  2. Zhiqiang Meng · 4 shared papers, 2016–2020 · strength 0.35
  3. Yongqiang Hua · 2 shared papers, 2016–2024 · strength 0.24
  4. Yehua Shen · 2 shared papers, 2016–2024 · strength 0.24
  5. Luming Liu · 3 shared papers, 2016–2021 · strength 0.24
  6. Qi Qi · 2 shared papers, 2018–2020 · strength 0.22
  7. Changjing Huang · 1 shared paper, 2024 · strength 0.20
  8. Hao Chen · 1 shared paper, 2024 · strength 0.20
  9. Peng Wang · 1 shared paper, 2024 · strength 0.20
  10. Chien‐shan Cheng · 1 shared paper, 2024 · strength 0.20
  11. Zhiqiang Meng · 1 shared paper, 2024 · strength 0.20
  12. Peng Wang · 2 shared papers, 2018 · strength 0.18
  13. Zhouyu Ning · 2 shared papers, 2016–2021 · strength 0.15
  14. Hao Chen · 2 shared papers, 2016–2018 · strength 0.13
  15. P Wang · 1 shared paper, 2020 · strength 0.13
  16. Lu-Ming Liu · 1 shared paper, 2020 · strength 0.13
  17. Simin Qi · 1 shared paper, 2021 · strength 0.11
  18. Libin Song · 1 shared paper, 2021 · strength 0.11
  19. Shengli Li · 1 shared paper, 2021 · strength 0.11
  20. Bo Zhang · 1 shared paper, 2021 · strength 0.11
  21. Jiang‐Jiang Qin · 1 shared paper, 2021 · strength 0.11
  22. Luming Liu · 1 shared paper, 2018 · strength 0.09
  23. Lei Wang · 1 shared paper, 2016 · strength 0.04
  24. Chenyue Zhang · 1 shared paper, 2016 · strength 0.04
  25. Jing Xie · 1 shared paper, 2016 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.